Cederquist represented the lenders in connection with Karo Pharma’s acquisition of a product portfolio with an aggregate value of MEUR 260 from the Danish pharmaceutical company LEO Pharma A/S.
Cederquist is legal advisor to the US biopharmaceutical company Alexion Pharmaceuticals, Inc. (Alexion) in connection with Alexion’s public cash offer for the shares in Wilson Therapeutics AB that are listed on Nasdaq Stockholm.
Cederquist represents NDX Intressenter AB, a bidding vehicle jointly established by Nordic Capital Fund VIII and Sampo plc, in connection with its public cash offer for Nordax Group AB (publ.).
Cederquist represents Axel Johnson AB in its acquisition of 70% of the shares in Skincity Sweden AB from the Skincity’s founders Annica Forsgren Kjellman and Mikael Kjellman and Rite Internet Ventures Holding AB.